5. https://draxe.com/scd-diet/
6. http://www.drperlmutter.com/learn/resources/probiotics-five-core-species.
7. Thrasher, J. D., M. R. Gray, K. H. Kilburn, D. P. Dennis, and A. Yu. A water-damaged home and health of occupants: a case study. Journal of Environmental and Public Health 2012, doi: 10.1155/2012/312836 (2012).
8. http://www.survivingmold.com/shoemaker-protocol/Certified-Physicians-Shoemaker-Protocol
9. https://www.functionalmedicine.org/practitioner_search.aspx?id=117.
10. Shoemaker, R. C., MD. Surviving Mold: Life in the Era of Dangerous Buildings. Otter Bay Books, 2010.
1. Galvan, V.,
2. Там же.
3. Theendakara, V., et al. Neuroprotective sirtuin ratio reversed by ApoE4. Proceedings of the National Academy of Science USA 110: 18303–18308, doi: 10.1073/pnas.1314145110 (2013).
4. Lourenзo, F. C., et al. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death and Differentiation 16: 655–663, doi: cdd2008191 [pii]10.1038/cdd.2008.191 (2009).
5. Lu, D. C., et al. A second cytotoxic proteolytic peptide derived from amyloid-beta-protein precursor. Nature Medicine 6: 397–404, doi:10.1038/74656 (2000).
6. Spilman, P., B. Jagodzinska, D. E. Bredesen, and John Varghese. Enhancement of sAPPα as a therapeutic strategy for Alzheimer’s and other neurodegenerative diseases. HSOA Journal of Alzheimer’s & Neurodegenerative Diseases 1: 1–10 (2015).
7. Spilman, P. R., et al. Netrin-1 interrupts amyloid-beta amplification, increases sAβPPα in vitro and in vivo, and improves cognition in a mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease 52: 223–242, doi: 10.3233/JAD-151046 (2016).
8. Julien, O., et al. Unraveling the mechanism of cell death induced by chemical fibrils. Nature Chemical Biology 10: 969–976, doi: 10.1038/nchembio.1639 (2014).
9. Matrone, C., et al. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. Journal of Alzheimer’s Disease 13: 81–96 (2008).
10. Bredesen, D. E. Reversal of cognitive decline: A novel therapeutic program. Aging 6: 707–717, doi: 10.18632/aging.100690 (2014).
11. Bredesen, D. E., et al. Reversal of cognitive decline in Alzheimer’s disease. Aging 8: 1250–1258, doi: 10.18632/aging.100981 (2016).